DK1725580T3 - Isosterisk transformation - Google Patents

Isosterisk transformation

Info

Publication number
DK1725580T3
DK1725580T3 DK05728233T DK05728233T DK1725580T3 DK 1725580 T3 DK1725580 T3 DK 1725580T3 DK 05728233 T DK05728233 T DK 05728233T DK 05728233 T DK05728233 T DK 05728233T DK 1725580 T3 DK1725580 T3 DK 1725580T3
Authority
DK
Denmark
Prior art keywords
terminal
group
amino group
carboxy
isosteric
Prior art date
Application number
DK05728233T
Other languages
English (en)
Inventor
Hans-Georg Frank
Karsten Knorr
Udo Haberl
Andreas Rybka
Original Assignee
Aplagen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1725580(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aplagen Gmbh filed Critical Aplagen Gmbh
Application granted granted Critical
Publication of DK1725580T3 publication Critical patent/DK1725580T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
DK05728233T 2004-03-17 2005-03-17 Isosterisk transformation DK1725580T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04006354 2004-03-17
PCT/EP2005/051256 WO2005090389A2 (en) 2004-03-17 2005-03-17 Isosteric transformation

Publications (1)

Publication Number Publication Date
DK1725580T3 true DK1725580T3 (da) 2009-03-23

Family

ID=34924503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05728233T DK1725580T3 (da) 2004-03-17 2005-03-17 Isosterisk transformation

Country Status (8)

Country Link
US (1) US20080305985A1 (da)
EP (1) EP1725580B1 (da)
JP (1) JP2007529475A (da)
AT (1) ATE421971T1 (da)
DE (1) DE602005012575D1 (da)
DK (1) DK1725580T3 (da)
SI (1) SI1725580T1 (da)
WO (1) WO2005090389A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415628B (zh) * 2006-02-28 2013-11-21 Avon Prod Inc 包含具有非天然胺基酸之胜肽之組合物及其使用方法
US8524669B2 (en) * 2008-10-17 2013-09-03 Dana-Farber Cancer Institute, Inc. MUC-1 cytoplasmic domain peptides as inhibitors of cancer
US11322228B2 (en) * 2015-10-30 2022-05-03 Janssen Vaccines & Prevention B.V. Structure based design of d-protein ligands
WO2020054813A1 (ja) * 2018-09-14 2020-03-19 エポメッド株式会社 抗エリスロポエチン受容体ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206339B (it) * 1984-01-13 1989-04-14 Anic Spa Analoghi retro-invertiti esapeptidici c-terminali della sostanza p.
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
PL185040B1 (pl) * 1995-06-07 2003-02-28 Affymax Tech Nv Peptyd wiążący się z receptorami erytropoetyny, kompozycja farmaceutyczna zawierająca ten peptyd i jego zastosowanie do wytwarzania środka leczniczego
ATE316097T1 (de) * 2000-01-20 2006-02-15 Univ Minnesota Peptide mit antibakterieller wirkung

Also Published As

Publication number Publication date
WO2005090389A3 (en) 2006-05-11
EP1725580B1 (en) 2009-01-28
DE602005012575D1 (en) 2009-03-19
US20080305985A1 (en) 2008-12-11
SI1725580T1 (sl) 2009-06-30
EP1725580A2 (en) 2006-11-29
JP2007529475A (ja) 2007-10-25
ATE421971T1 (de) 2009-02-15
WO2005090389A2 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
ES2616658T3 (es) Péptidos que mimetizan el factor de crecimiento y sus usos
ES2571879T3 (es) Moléculas de una sola cadena de TNFSF
JP2005516072A5 (da)
IN2014CN02050A (da)
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
ES2531142T3 (es) Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
WO2009069808A1 (ja) 新規活性を有するEphA4ポリペプチドおよびその用途
AU2003239659A1 (en) Peptide epitopes common to antigens of the same multigene family
WO2007036299A3 (de) Verfahren zur amidierung von polypeptiden mit c-terminalen basischen aminosäuren unter verwendung spezifischer endoproteasen
WO2006054262A3 (en) Use of phage display technique for identifying peptides capable of binding progenitor/stem cells, peptides thereby obtained and uses thereof
ATE453664T1 (de) Hausstaubmilbenallergen
ES2507094T3 (es) Proteína específica del timo
RU2010142486A (ru) Частичный пептид лакритина
MX2010005816A (es) Epítopos de péptido de stat3.
DE602007010969D1 (de) Zytokinderivate
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
ATE421971T1 (de) Isostere transformation
ES2557938T3 (es) Antagonistas de resistina y su uso
NZ591133A (en) Novel melanoma antigen peptide and uses thereof
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil
NO20082864L (no) Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav
WO2024251939A3 (en) Ccr1 modulators and methods of use
DE602005018326D1 (de) Für orotat-transporter codierende markergene